| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.079 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.089 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.1 | 0.04 |